November 2024, Launch of Methylated DNA Control Sample

November 2024, Gamidor Diagnostics receives distribution rights from Self-screen to market PreCursor-M family of methylation-specific molecular assays to identify high risk for HPV induced cancers.

March 2024, Self-screen and Fujirebio Europe launch PreCursor-M AnoGYN assay (RUO) for methylation testing in anal specimens

February 2024, Self-sampling workflow NeuMoDx HPV assay validated for screening purposes

January 2024, SELF-SCREEN SUCCESFULLY ISO13485 RE-ACCREDITED

July 2023, SELF-SCREEN NEW LOCATION